AnaptysBio Inc (NASDAQ:ANAB)
| 14.08 Delayed Data As of Nov 29 |  +0.23 / +1.66%Today’s Change | 13.36 Today|||52-Week Range 32.44 | -54.57% Year-to-Date |
Institutional investors purchased a net $723.4 thousand shares of ANAB during the quarter ended June 2019 and now own 104.92% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
| Other institutional | 81.99% |
| Individual stakeholders | 47.13% |
| Mutual fund holders | 22.94% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 9/30/2023 | SATURN V CAPITAL MANAGEMENT LLC Bought 577.1 Thousand shares of AnaptysBio Inc |
| 9/30/2023 | SUVRETTA CAPITAL MANAGEMENT LLC Bought 479.4 Thousand shares of AnaptysBio Inc |
| 9/30/2023 | FIRST LIGHT ASSET MANAGEMENT LLC Bought 468.6 Thousand shares of AnaptysBio Inc |
Top 10 Owners of AnaptysBio Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 28.33% | 7,521,024 | 122,667,901 | 0 | 0.00% |
| Tang Capital Management LLC | 7.35% | 1,950,609 | 31,814,433 | 0 | 0.00% |
| The Vanguard Group, Inc. | 6.24% | 1,656,892 | 27,023,909 | -72,932 | -4.22% |
| BlackRock Fund Advisors | 5.84% | 1,548,948 | 25,263,342 | +10,937 | +0.71% |
| Deep Track Capital LP | 5.12% | 1,360,176 | 22,184,471 | +14,363 | +1.07% |
| Braidwell LP | 3.96% | 1,049,823 | 17,122,613 | -104,600 | -9.06% |
| SSgA Funds Management, Inc. | 3.52% | 933,362 | 15,223,134 | -279,452 | -23.04% |
| Great Point Partners LLC | 3.37% | 894,333 | 14,586,571 | 0 | 0.00% |
| Woodline Partners LP | 3.17% | 840,821 | 13,713,791 | -193,728 | -18.73% |
| Point72 Asset Management LP | 2.98% | 791,200 | 12,904,472 | -668,709 | -45.80% |
Top 10 Mutual Funds Holding AnaptysBio Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Vanguard Total Stock Market ETF | 2.16% | 574,301 | 9,366,849 | 0 | 0.00% |
| SPDR S&P Biotech ETF | 2.04% | 540,187 | 8,810,450 | +3,230 | +0.60% |
| iShares Russell 2000 ETF | 1.71% | 452,546 | 7,381,025 | -4,543 | -0.99% |
| Vanguard Small Cap Index Fund | 1.67% | 443,423 | 7,232,229 | +216 | +0.05% |
| Fidelity Select Port. - Biotechno... | 1.00% | 265,328 | 4,327,500 | -23,900 | -8.26% |
| Vanguard Small Cap Growth Index F... | 0.93% | 247,997 | 4,044,831 | -188 | -0.08% |
| Vanguard Extended Market Index Fu... | 0.92% | 245,148 | 3,998,364 | +11,104 | +4.74% |
| FTIF SICAV - Biotechnology Discov... | 0.85% | 224,616 | 3,663,487 | +209,363 | +1,372.60% |
| Fidelity Small Cap Index Fund | 0.66% | 174,135 | 2,840,142 | +3,959 | +2.33% |
| iShares Biotechnology ETF | 0.63% | 166,152 | 2,709,939 | -453 | -0.27% |